389 related articles for article (PubMed ID: 9629839)
1. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene.
Cudkowicz ME; McKenna-Yasek D; Chen C; Hedley-Whyte ET; Brown RH
Ann Neurol; 1998 Jun; 43(6):703-10. PubMed ID: 9629839
[TBL] [Abstract][Full Text] [Related]
2. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
Iwata NK
Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
[TBL] [Abstract][Full Text] [Related]
3. Familial amyotrophic lateral sclerosis with bulbar onset and a novel Asp101Tyr Cu/Zn superoxide dismutase gene mutation.
Tan CF; Piao YS; Hayashi S; Obata H; Umeda Y; Sato M; Fukushima T; Nakano R; Tsuji S; Takahashi H
Acta Neuropathol; 2004 Oct; 108(4):332-6. PubMed ID: 15235802
[TBL] [Abstract][Full Text] [Related]
4. Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis.
Hong YH; Lee KW; Sung JJ; Chang KH; Song IC
J Neurol Sci; 2004 Dec; 227(1):73-8. PubMed ID: 15546594
[TBL] [Abstract][Full Text] [Related]
5. Familial amyotrophic lateral sclerosis with Gly93Ser mutation in Cu/Zn superoxide dismutase: a clinical and neuropathological study.
Suzuki M; Irie T; Watanabe T; Mikami H; Yamazaki T; Oyanagi K; Ono S
J Neurol Sci; 2008 May; 268(1-2):140-4. PubMed ID: 18191946
[TBL] [Abstract][Full Text] [Related]
6. Expression of the copper-zinc superoxide dismutase gene in amyotrophic lateral sclerosis.
Nishiyama K; Murayama S; Kwak S; Kanazawa I
Ann Neurol; 1997 Apr; 41(4):551-6. PubMed ID: 9124814
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the Cu/Zn superoxide dismutase gene in 23 familial and 69 sporadic cases of amyotrophic lateral sclerosis in Belgium.
Aguirre T; Matthijs G; Robberecht W; Tilkin P; Cassiman JJ
Eur J Hum Genet; 1999 Jul; 7(5):599-602. PubMed ID: 10439968
[TBL] [Abstract][Full Text] [Related]
8. The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis.
Régal L; Vanopdenbosch L; Tilkin P; Van den Bosch L; Thijs V; Sciot R; Robberecht W
Arch Neurol; 2006 Feb; 63(2):262-7. PubMed ID: 16476815
[TBL] [Abstract][Full Text] [Related]
9. Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn superoxide dismutase mutation.
Aoki M; Abe K; Houi K; Ogasawara M; Matsubara Y; Kobayashi T; Mochio S; Narisawa K; Itoyama Y
Ann Neurol; 1995 May; 37(5):676-9. PubMed ID: 7755363
[TBL] [Abstract][Full Text] [Related]
10. Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress.
Aguirre T; Van Den Bosch L; Goetschalckx K; Tilkin P; Mathijs G; Cassiman JJ; Robberecht W
Ann Neurol; 1998 Apr; 43(4):452-7. PubMed ID: 9546325
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.
Nakamura M; Ito H; Wate R; Nakano S; Hirano A; Kusaka H
Acta Neuropathol; 2008 Mar; 115(3):327-34. PubMed ID: 18210139
[TBL] [Abstract][Full Text] [Related]
12. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation.
Tan CF; Eguchi H; Tagawa A; Onodera O; Iwasaki T; Tsujino A; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol; 2007 May; 113(5):535-42. PubMed ID: 17333220
[TBL] [Abstract][Full Text] [Related]
13. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Reinholz MM; Merkle CM; Poduslo JF
Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
[TBL] [Abstract][Full Text] [Related]
15. [On intra-familial clinical diversities of a familial amyotrophic lateral sclerosis with a point mutation of Cu/Zn superoxide dismutase (Asn 86-Ser].
Maeda T; Kurahashi K; Matsunaga M; Inoue K; Inoue M
No To Shinkei; 1997 Sep; 49(9):847-51. PubMed ID: 9311004
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel D109Y mutation in Cu/Zn superoxide dismutase (sod1) gene associated with amyotrophic lateral sclerosis.
Naini A; Mehrazin M; Lu J; Gordon P; Mitsumoto H
J Neurol Sci; 2007 Mar; 254(1-2):17-21. PubMed ID: 17257622
[TBL] [Abstract][Full Text] [Related]
17. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis.
Rouleau GA; Clark AW; Rooke K; Pramatarova A; Krizus A; Suchowersky O; Julien JP; Figlewicz D
Ann Neurol; 1996 Jan; 39(1):128-31. PubMed ID: 8572658
[TBL] [Abstract][Full Text] [Related]
18. A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset and incomplete penetrance in China.
Zhang H; Zhao H; Lu M; Zhang Y; Wang L; Zhang J; Ma D; Fan D
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Dec; 6(4):234-8. PubMed ID: 16319027
[TBL] [Abstract][Full Text] [Related]
19. Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypes.
Broom WJ; Russ C; Sapp PC; McKenna-Yasek D; Hosler BA; Andersen PM; Brown RH
Neurosci Lett; 2006 Jan; 392(1-2):52-7. PubMed ID: 16174551
[TBL] [Abstract][Full Text] [Related]
20. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation.
Jackson M; Al-Chalabi A; Enayat ZE; Chioza B; Leigh PN; Morrison KE
Ann Neurol; 1997 Nov; 42(5):803-7. PubMed ID: 9392581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
